Clinical Trial Update: Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing sofosbuvir/simeprevir plus a flat dose of ribavirin in genotype 1 elderly patients with liver cirrhosis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Hepatitis C

Drugs mentioned

• Copegus (ribavirin)
• Olysio (Simeprevir)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Azienda Ospedaliera San Camillo Forlanini | Conditions: Liver Cirrhosis | Phase 4 | Status: COMPLETED